Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction
Authors:
- Marco MetraMMMarco Metra
- Gad CotterGCGad Cotter
- Piotr PonikowskiPPPiotr Ponikowski
- John G.F. ClelandJCJohn G.F. Cleland
- Christopher M. O'COnnorCOChristopher M. O'COnnor
Abstract
No abstract availableKeywords
Funding Information
- NovaCardia, Inc.
- Merck-NovaCardia
- NovaCardia
This publication has 29 references indexed in Scilit:
- Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart FailureNew England Journal of Medicine, 2010
- Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular DiseaseJACC, 2009
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart FailureJACC, 2009
- Role of Adenosine Antagonism in the Cardiorenal SyndromeCardiovascular Therapeutics, 2008
- Peripheral plasma adenosine release in patients with chronic heart failureHeart, 2008
- Secular Trends in Renal Dysfunction and Outcomes in Hospitalized Heart Failure PatientsJournal of Cardiac Failure, 2006
- Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH)European Heart Journal, 2006
- Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failureThe American Journal of Cardiology, 2004
- Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failureThe American Journal of Cardiology, 2000
- Role of the Kidney in Congestive Heart FailureDrugs, 1990